Nikhil Prasad Fact checked by:Thailand Medical News Team Apr 26, 2026 1 hour, 38 minutes ago
Medical News:
A Breakthrough in Understanding Brain Disorders
Scientists from Washington University School of Medicine in St. Louis have made a major breakthrough in understanding some of the most complex brain diseases affecting millions worldwide. By studying proteins found in blood and spinal fluid, researchers have uncovered distinct biological “fingerprints” that can help identify and differentiate between four major brain disorders—Alzheimer’s disease, Parkinson’s disease, dementia with Lewy bodies, and frontotemporal dementia.
New research shows blood and spinal fluid proteins can help detect and distinguish major brain diseases earlier
than ever before
Led by Professor Carlos Cruchaga and first author Muhammad Ali, the research team analyzed nearly 7,000 proteins from samples taken from close to 6,000 individuals. These included both healthy participants and those diagnosed with neurodegenerative diseases. Their findings provide new hope for earlier diagnosis and more targeted treatment strategies.
What Makes These Diseases So Difficult to Diagnose?
These brain diseases often share similar symptoms such as memory loss, confusion, and movement problems. Because of this overlap, doctors sometimes struggle to distinguish between them early on. This delay can affect treatment outcomes and patient care.
This
Medical News report highlights how the researchers tackled this challenge by studying both cerebrospinal fluid (which surrounds the brain and spinal cord) and blood plasma. By comparing these two sources, they were able to identify both shared and unique biological changes linked to each disease.
Key Findings from the Study
The study revealed that all four diseases share certain underlying problems. These include chronic inflammation, damage to connections between brain cells, and disruptions in the structural support around cells known as the extracellular matrix.
However, each disease also showed its own unique protein patterns. For example:
Alzheimer’s disease showed disruptions in protein processing and cell death pathways.
Parkinson’s disease was linked to stress responses within cells and communication breakdowns between neurons.
Dementia with Lewy bodies displayed strong inflammatory signals and growth factor disruptions.
Frontotemporal dementia showed changes affecting hormone-related proteins and brain cell development.
One of the most striking discoveries was that spinal fluid provided clearer and more disease-specific signals than blood. Still, blood samples were surprisingly effective, opening the door to simpler and less invasive diagnostic tests in the future.
The researchers di
d not just find general patterns—they mapped out specific proteins, genes, and cellular pathways that are altered in each disease, offering a much deeper and more precise understanding of what is going wrong in the brain.
One of the strongest shared findings across all four conditions was the disruption of immune-related pathways, particularly those involving cytokines and interleukin signaling. Proteins linked to inflammatory responses—such as IL-6, TNF-related signaling molecules, and interleukin receptors like IL-27RA and IL-20RB—were consistently altered. These molecules are normally involved in defending the body, but when overactivated in the brain, they can drive long-term inflammation that damages neurons. This confirms that neuroinflammation is not just a secondary effect but a central mechanism in neurodegeneration.
Another major shared feature involved synaptic proteins, which are critical for communication between neurons. Key proteins such as NPTX2, NPTXR, and NRGN (neurogranin) showed altered levels, indicating breakdown of synaptic signaling. These proteins are directly involved in maintaining learning and memory functions, and their disruption helps explain cognitive decline seen across multiple diseases.
The study also highlighted widespread changes in the extracellular matrix (ECM), with proteins like ITGB2 (integrin beta-2) and other structural regulators being affected. The ECM acts as a support scaffold for brain cells, and its disruption can weaken neuronal stability and impair repair mechanisms.
Alzheimer’s Disease: Protein Misfolding and Cell Death Pathways
Alzheimer’s disease showed the most extensive molecular disruption. The researchers identified abnormalities in proteins involved in glycosylation pathways, particularly B4GALT1 and FUCA1, which are crucial for proper protein folding and stability. When these pathways fail, toxic proteins such as amyloid-beta and tau accumulate more easily.
There was also strong activation of apoptotic (cell death) pathways, along with proteins like SMOC1, YWHAG, and ACHE (acetylcholinesterase). These findings suggest that neurons are not only damaged but actively pushed toward programmed death. Additionally, PI3K/AKT signaling pathways, which normally promote cell survival, were disrupted, further accelerating neurodegeneration.
Parkinson’s Disease: Cellular Stress and Dopamine Neuron Loss
In Parkinson’s disease, the study pointed to disruptions in endoplasmic reticulum (ER) stress pathways, particularly involving ATF4 and PERK signaling. These pathways are activated when cells are overwhelmed by misfolded proteins, such as alpha-synuclein, a hallmark of Parkinson’s.
Specific proteins like PRDX3 (an antioxidant enzyme), CD2AP, ILK, and SOX10 were identified as altered, indicating problems in oxidative stress management and cell survival. The activation of ATF4-mediated stress responses can trigger downstream apoptotic pathways, leading to the loss of dopamine-producing neurons in the brain.
The study also found changes in receptor tyrosine kinase signaling, involving proteins such as FYN, LCK, and STAT6, which play roles in cell communication and immune responses. These disruptions may contribute to both inflammation and neuronal death.
Dementia with Lewy Bodies: Inflammation and Growth Factor Disruption
Dementia with Lewy bodies (DLB) showed particularly strong activation of interleukin signaling pathways, especially IL-4 and IL-13 pathways, involving proteins like JAK2 and CCL11. These pathways indicate an amplified immune response within the brain.
In addition, the study identified disruptions in fibroblast growth factor receptor (FGFR) signaling, including proteins such as FGFR3. This pathway is essential for neuron survival and repair, suggesting that in DLB, the brain’s ability to maintain and regenerate neurons is compromised.
Interestingly, proteins like SPC25 and NEGR1 were newly associated with DLB, pointing to previously unknown mechanisms that may contribute to disease progression.
Frontotemporal Dementia: Hormonal and Gene Regulation Disruption
Frontotemporal dementia (FTD) stood out for its effects on glycoprotein hormone pathways and transcriptional regulation systems. Proteins such as PCSK1N, CXCL12, and TGFBR3 were significantly altered, indicating disruptions in signaling that affect brain development and function.
The study also found involvement of ERBB2 signaling and interferon pathways, both of which are linked to inflammation and communication between neurons and supporting cells like astrocytes. These disruptions may explain why FTD often affects behavior, personality, and decision-making rather than memory in its early stages.
Cerebrospinal Fluid vs Blood: A Critical Difference
A key technical finding was that cerebrospinal fluid (CSF) contained far more disease-specific protein changes than blood plasma. Over 50% of the proteins identified in CSF were completely new associations, including RAB14, IL-7, and CXCL12. This makes CSF a more direct and sensitive indicator of brain pathology. However, blood still showed important markers such as SOD3, NRXN3, and PPP2R5A, suggesting that less invasive blood tests could still be useful for diagnosis, especially when combined with advanced computational models.
A New Level of Precision in Disease Detection
By integrating all these protein changes, the researchers built machine learning models with high diagnostic accuracy (AUC up to 0.95 in CSF). These models can distinguish between diseases based on their molecular signatures, something that has been extremely difficult using symptoms alone.
Overall, the study provides a detailed molecular roadmap of neurodegeneration, identifying not just general mechanisms but specific proteins and pathways driving each disease, opening the door to highly targeted diagnostics and treatments.
The Power of Machine Learning in Diagnosis
Using these protein patterns, the researchers developed advanced computer models capable of identifying each disease with high accuracy. In some cases, these models performed as well as current gold-standard methods like PET scans.
This means that, in the future, a simple blood test could help doctors diagnose brain diseases earlier and more precisely. It could also help track how a disease progresses or how well a patient responds to treatment.
Why This Research Matters
Beyond diagnosis, the study also sheds light on how these diseases develop. By identifying both shared and disease-specific pathways, scientists can better understand which treatments might work across multiple conditions and which need to be tailored.
For instance, therapies targeting inflammation or the blood-brain barrier could potentially benefit several types of dementia. At the same time, disease-specific treatments could focus on the unique molecular changes identified in each condition.
Study Limitations and Future Directions
While the findings are promising, researchers note some limitations. Most participants were from similar ethnic backgrounds, which may affect how widely the results apply. Additionally, some diseases like frontotemporal dementia had smaller sample sizes, which may impact accuracy.
Future studies will aim to include more diverse populations and larger datasets. Scientists also plan to combine these findings with genetic data to gain even deeper insights into disease mechanisms.
Conclusion
This groundbreaking study marks a major step forward in the fight against neurodegenerative diseases. By uncovering detailed protein signatures in both blood and spinal fluid, researchers have opened the door to earlier diagnosis, better disease monitoring, and more personalized treatments. The ability to detect these conditions through simple blood tests could transform how doctors approach brain health, offering patients faster answers and more effective care. While more research is needed, these findings bring renewed hope for millions affected by these devastating disorders.
The study findings were published in the peer reviewed journal: Neuron.
https://www.cell.com/neuron/fulltext/S0896-6273(26)00140-6
For the latest research on Neurodegenerative-Diseases, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/articles/alzheimer,-dementia-
Share
Tweet
Share
